TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 4, Issue 3, 2017
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
A Friend  | A librarian
Purchase
Purchase Issue
Abstract
Title
MUCORMYCOSIS: PROGNOSIS, DIAGNOSIS AND THERAPYCURRENT TRENDS
Author
Adarsh KL, Poojitha PJ, Malathi M, Pravallika P
Email
paladugupravallika896@gmail.com
keyword
Mucosis, Immunocompromised, Antifungal Agents, Cutaneous Infection
Abstract
Mucormycosis, an aggressive and potentially life-threatening fungal infection, presents multifaceted challenges in diagnosis, treatment, and prognosis. This review explores the diverse clinical spectrum of mucormycosis, encompassing its etiology rooted in environmental fungi, risk factors amplifying susceptibility, and intricate clinical manifestations affecting various organ systems. Diagnostic approaches, including imaging modalities and tissue biopsies, alongside management strategies such as antifungal therapy and surgical intervention, are delineated. Emphasizing the importance of an interprofessional approach, the abstract underscores the collaborative efforts of specialists from infectious diseases, otolaryngology, hematology/oncology, endocrinology, microbiology, and dedicated nursing and pharmacy support. Despite advancements, the prognosis for mucormycosis remains challenging, particularly without immune status restoration, urging further exploration and innovative approaches for improved patient outcomes
Download Broucher
Back to Top >>>>